Loading...
•
Sep 30, 2023
Stryker Q3 2023 Earnings Report
Stryker reported strong organic sales growth and continued margin expansion in Q3 2023.
Key Takeaways
Stryker's Q3 2023 results showed a 9.6% increase in reported net sales, reaching $4.9 billion. Organic net sales grew by 9.2%. The adjusted EPS increased by 16.0% to $2.46.
Reported net sales increased 9.6% to $4.9 billion.
Organic net sales increased 9.2%.
Adjusted EPS increased 16.0% to $2.46.
Company expects full year 2023 organic net sales growth to be in the range of 10.0% to 10.5%.
Forward Guidance
Stryker expects full year 2023 organic net sales growth to be in the range of 10.0% to 10.5% including slightly positive pricing for the year. Adjusted net earnings per diluted share are expected to be in the range of $10.35 to $10.45.
Positive Outlook
- Robust backlog for capital equipment
- Continued positive procedural trends
Challenges Ahead
- Foreign exchange rates may unfavorably impact net sales by approximately 0.6% for the full year
- Adjusted net earnings per diluted share will be unfavorably impacted by $0.10 to $0.15 for the full year due to foreign exchange rates
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...